Massive $1.5B investment in manufacturing widens Eli Lilly's footprint in Ireland and North Carolina

Date Published01/28/2022
Author NameJosh Sullivan

Additional Reshoring Information:

Company/Division name Eli Lilly and Company
Parent companyEli Lilly and Company
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):600
What product(s) and/or service(s) were outsourced domestically?Manufacturing
Year reshoring announced:2022
Domestically, the work will be done:In-house
Capital investment ($):15000
City reshored to:Concord
State(s) reshored to:NC
If relevant, work nearshored to:-
Product(s) reshoredDiabetes, cancer, Alzheimer, obesity medication
What domestic positive factors made reshoring more attractive?Government Incentives, Skilled workforce availability/training
Find Reshoring Articles